Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Management of Isolated Systolic Hypertension

Introduction to Isolated Systolic Hypertension

  • Isolated systolic hypertension is common, particularly in older adults, and is associated with increased cardiovascular risk 1
  • Treatment requires careful medication selection to avoid further lowering of diastolic pressure, which could compromise coronary perfusion 2

First-Line Treatment Options

  • The European Society of Cardiology recommends dihydropyridine calcium channel blockers (CCBs) as a first-line treatment for isolated systolic hypertension due to their efficacy in reducing systolic blood pressure with minimal impact on diastolic pressure 1
  • Angiotensin receptor blockers (ARBs) are also effective for isolated systolic hypertension with minimal effect on diastolic pressure, and are less likely to cause postural hypotension compared to some other antihypertensives 1, 2

Second-Line Options

  • Low-dose thiazide or thiazide-like diuretics are effective in reducing systolic blood pressure in elderly patients, but should be used cautiously in patients with already low diastolic pressure due to potential for orthostatic hypotension 1, 2
  • ACE inhibitors can be effective for isolated systolic hypertension, and may be particularly beneficial in patients with comorbidities like diabetes or chronic kidney disease 1, 3

Treatment Approach

  • Initial assessment should include evaluation for orthostatic hypotension, which is more common in elderly patients with isolated systolic hypertension, and consideration of comorbidities that might influence medication choice 1, 3
  • First-line treatment should start with a dihydropyridine CCB (e.g., amlodipine) at a low dose, with initial doses being more gradual in elderly patients 1
  • Monitoring and titration should include assessing both sitting and standing blood pressure to detect orthostatic hypotension, and titrating medication gradually to achieve target systolic BP (120-129 mmHg) while maintaining adequate diastolic BP 1, 2, 3

Special Considerations

  • Elderly patients are more susceptible to orthostatic hypotension, and initial doses and subsequent titration should be more gradual, with a target systolic BP of 120-129 mmHg if tolerated 1, 3
  • Excessive lowering of diastolic BP (<60 mmHg) can compromise coronary perfusion, and beta-blockers may be less effective for isolated systolic hypertension in elderly patients 1
  • Regular follow-up is necessary to assess efficacy and adverse effects, and home BP monitoring can help detect orthostatic hypotension and guide therapy 3, 4